LSE - Delayed Quote GBp

N4 Pharma Plc (N4P.L)

0.4750
0.0000
(0.00%)
At close: May 30 at 10:28:07 AM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1.9530
1.9530
0
0
0
Operating Expense
1,337.3720
1,337.3720
1,193.2600
1,843.2900
1,564.4210
Operating Income
-1,335.4190
-1,335.4190
-1,193.2600
-1,843.2900
-1,564.4210
Net Non Operating Interest Income Expense
0
0
0.0010
0.6770
-1.1500
Pretax Income
-1,424.5940
-1,424.5940
-1,193.2590
-1,842.6130
-1,566.3840
Tax Provision
-147.8160
-147.8160
-163.9980
-298.2670
-261.5410
Net Income Common Stockholders
-1,269.3310
-1,269.3310
-1,029.2610
-1,544.3460
-1,304.8430
Diluted NI Available to Com Stockholders
-1,269.3310
-1,269.3310
-1,029.2610
-1,544.3460
-1,304.8430
Basic EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Diluted EPS
-0.01
-0.01
-0.01
-0.01
-0.01
Basic Average Shares
242,889.9380
242,889.9380
186,422.5410
181,080.3490
136,303.1410
Diluted Average Shares
242,889.9380
242,889.9380
186,422.5410
181,080.3490
139,432.2260
Total Operating Income as Reported
-1,424.5940
-1,424.5940
-1,193.2600
-1,843.2900
-1,564.4210
Total Expenses
1,337.3720
1,337.3720
1,193.2600
1,843.2900
1,564.4210
Net Income from Continuing & Discontinued Operation
-1,269.3310
-1,269.3310
-1,029.2610
-1,544.3460
-1,304.8430
Normalized Income
-1,269.3310
-1,269.3310
-1,029.2610
-1,544.3460
-1,304.8430
Interest Income
0
0
0.0010
0.6770
--
Interest Expense
--
--
--
--
1.9630
Net Interest Income
0
0
0.0010
0.6770
-1.1500
EBIT
-1,335.4190
-1,335.4190
-1,193.2600
-1,843.2900
-1,564.4210
EBITDA
-1,335.4190
-1,335.4190
-1,193.2600
-1,843.2900
-1,564.4210
Net Income from Continuing Operation Net Minority Interest
-1,269.3310
-1,269.3310
-1,029.2610
-1,544.3460
-1,304.8430
Normalized EBITDA
-1,335.4190
-1,335.4190
-1,193.2600
-1,843.2900
-1,564.4210
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0.0002
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2020 - 7/1/1988

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SBX.BE SynBiotic SE
3.3000
-1.35%
 
TBET Tibet Pharmaceuticals, Inc.
0.0000
0.00%
 
8BN.BE Optimi Health Corp
0.1070
+3.88%
 
EVT.MU Evotec SE
7.00
-1.57%
 
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
0.00%
 
2HQ.DU Tilray Brands Inc
0.3849
-2.78%
 
EAH.L ECO Animal Health Group plc
61.00
0.00%
 
SFZNz.XC
 
GLENMARK.BO Glenmark Pharmaceuticals Limited
1,457.75
+4.38%
 
SECARE.ST Swedencare AB (publ)
40.00
-0.74%